We are live on ! Find out more
MIP

Mondrian Investment Partners Portfolio holdings

AUM $6.48B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+18.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5B
AUM Growth
+$470M
Cap. Flow
+$194M
Cap. Flow %
3.88%
Top 10 Hldgs %
35.26%
Holding
95
New
5
Increased
34
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
TRP icon
TC Energy
TRP
+$84M
2
SQM icon
Sociedad Química y Minera de Chile
SQM
+$72.6M
3
CDW icon
CDW
CDW
+$71.6M
4
INFY icon
Infosys
INFY
+$35.2M
5
KT icon
KT
KT
+$34.6M

Sector Composition

Rank Sector Weight
1 Healthcare 20.7%
2 Financials 17.92%
3 Technology 14.57%
4 Energy 11.82%
5 Communication Services 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
26
TSMC
TSM
$2.15T
$94.3M 1.88%
933,944
-220,092
-19% -$20.5M
INFY icon
27
Infosys
INFY
$45.8B
$85.4M 1.71%
5,312,153
+2,252,695
+74% +$35.2M
V icon
28
Visa
V
$701B
$79.8M 1.6%
335,993
-8,654
-3% -$1.98M
CDW icon
29
CDW
CDW
$19.2B
$75.2M 1.5%
+409,930
New +$71.6M
SQM icon
30
Sociedad Química y Minera de Chile
SQM
$19.8B
$74.2M 1.48%
+1,021,621
New +$72.6M
SAN icon
31
Banco Santander
SAN
$213B
$74M 1.48%
19,947,142
SONY icon
32
Sony
SONY
$140B
$73.2M 1.46%
4,064,815
MU icon
33
Micron Technology
MU
$1.05T
$71.8M 1.44%
1,137,350
-417,897
-27% -$26.9M
ITUB icon
34
Itaú Unibanco
ITUB
$91B
$67.2M 1.34%
12,896,818
-451,270
-3% -$2.13M
NVS icon
35
Novartis
NVS
$263B
$67.1M 1.34%
664,627
-23,000
-3% -$2.3M
PHG icon
36
Philips
PHG
$24.3B
$66.7M 1.33%
3,438,264
+436,063
+15% +$7.63M
GSK icon
37
GSK
GSK
$100B
$65.8M 1.32%
1,845,585
+409,479
+29% +$14.7M
SNY icon
38
Sanofi
SNY
$102B
$64.4M 1.29%
1,195,169
-106,000
-8% -$5.7M
TAK icon
39
Takeda Pharmaceutical
TAK
$59.7B
$64.1M 1.28%
4,081,715
HMC icon
40
Honda
HMC
$41.8B
$62.2M 1.24%
2,050,969
-172,000
-8% -$4.86M
LYG icon
41
Lloyds Banking Group
LYG
$84.9B
$59M 1.18%
26,795,456
WPP icon
42
WPP
WPP
$5.57B
$58.3M 1.17%
1,114,886
+53,000
+5% +$2.98M
BP icon
43
BP
BP
$121B
$52.8M 1.06%
1,497,152
MMS icon
44
Maximus
MMS
$3.05B
$48.9M 0.98%
579,130
-138,460
-19% -$11.4M
KT icon
45
KT
KT
$9.45B
$33.6M 0.67%
+2,971,491
New +$34.6M
HDB icon
46
HDFC Bank
HDB
$116B
$28.1M 0.56%
807,568
-3,080
-0.4% -$104K
DLTR icon
47
Dollar Tree
DLTR
$21.2B
$25.9M 0.52%
180,522
+179,188
+13,432% +$26.4M
RDY icon
48
Dr. Reddy's Laboratories
RDY
$9.62B
$16.9M 0.34%
1,335,955
-112,570
-8% -$1.31M
PEP icon
49
PepsiCo
PEP
$185B
$6.81M 0.14%
36,768
-21,179
-37% -$3.95M
CINT icon
50
CI&T Inc
CINT
$403M
$5.2M 0.1%
829,595
+85,163
+11% +$411K

Similar funds

Mondrian Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Mondrian Investment Partners held 95 positions worth $5B, up 10% from $4.53B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mondrian Investment Partners deployed $194M of net new capital in Q2 2023, opening 5 new positions and adding to 34 existing holdings. Its largest new stake was Sociedad Química y Minera de Chile: 1,021,621 shares worth $74.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $55.1M trimmed.

  • Mondrian Investment Partners's largest Q2 2023 buy was Sociedad Química y Minera de Chile: 1,021,621 shares worth $74.2M.
  • Mondrian Investment Partners added most to TC Energy in Q2 2023, an estimated $84M increase.
  • Mondrian Investment Partners's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $55.1M.
  • Mondrian Investment Partners fully exited Pinnacle Financial Partners Inc in Q2 2023, selling an estimated $21.9M.
  • Mondrian Investment Partners's ten largest holdings make up 35% of its $5B portfolio in Q2 2023.
  • Mondrian Investment Partners opened 5 new positions and closed 7 in Q2 2023.
  • Mondrian Investment Partners's portfolio value rose 10% quarter-over-quarter to $5B.

Based on Mondrian Investment Partners's 13F filing for Q2 2023, filed 10 Aug 2023.